Based on its recent analysis of the surgical robotics for neurosurgical interventions market, Frost & Sullivan recognises Medtech SAS with the prestigious 2013 European Company of the Year Award.
Medtech SAS is commended for its innovative ROSA™ system, which successfully addresses the need for an accurate, economical and clinically effective solution for patients requiring neurological interventions.
"As a robotic surgery system, ROSA™ performs the function of a surgical assistant for neurosurgical procedures," notes Frost & Sullivan Healthcare Industry Analyst Beulah Devadason . "The integration of all neurosurgical requirements and the broad range of procedures that can be performed using ROSA™ make it a true technological innovation in the field of neurosurgery."
Preoperative planning, surgical navigation and integration of intraoperative imaging are necessary to ensure a high degree of safety and accuracy in neurosurgery. ROSA™ is perfectly designed to integrate all these important surgical steps but also to incorporate very precise instrument manipulation.
ROSA™ enables open-skull, stereotactic and NeuroEndoscopic surgeries. The combination of planning, navigation and instrument manipulation facilitate shorter surgery times coupled with minimally invasive interventions in a fully frameless environment.
The shortening of procedure times, which may be up to 50 per cent for certain indications, enables tangible cost savings through simplified workflow, shorter operating room time and reduced surgeon workload, thus allowing multiple procedures within the same day. This further enhances the return on investment for hospitals.